Central Nervous System Correlates of Behavioral Deficits Following Simian Immunodeficiency Virus Infection

References

• Arendt G, Hefter H, Buescher L, Hilperath F, Elsing C, Freund HJ (1992). Improvement of motor performance of HIV-positive patients under AZT therapy. Neurology 42: 891–896.
   PubMed Web of Science ®Google Scholar
• Arendt G, Hefter H, Elsing C, Neuen-Jakob E, Strohmeyer G, Freund HJ (1989). New electrophysiological findings on the incidence of brain involvement in clinically and neurologically asymptomatic HIV infections]. EEG EMG Z Elelctroenzephalogr Elektromyogr Verwandte Geb 20: 280–287.
   Google Scholar
• Arendt G, Hefter H, Elsing C, Strohmeyer G, Freund HJ (1990). Motor dysfunction in HIV-infected patients with-out clinically detectable central-nervous deficit. I Neurol 237: 362–368.
   PubMed Web of Science ®Google Scholar
• Arendt G, Hefter H, Hilperath F, von Giesen HJ, Strohmeyer G, Freund HJ (1994). Motor analysis predicts progression in HIV-associated brain disease. J Neurol Sci 123: 180–185.
   Google Scholar
• Bacellar H, Munoz A, Miller EN, Cohen BA, Besley D, Selnes OA, Becker JT, McArthur JC (1994). Temporal trends in the incidence of HIV-1-related neurologic dis-eases: Multicenter AIDS Cohort Study, 1985–1992. Neu-rology 44: 1892–1900.
   Google Scholar
• Berman NE, Marcario JK, Yong C, Raghavan R, Raymond LA, Joag SV, Narayan O, Cheney PD (1999). Microglial activation and neurological symptoms in the SW model of NeuroAIDS: association of MHC-II and MMP-9 ex-pression with behavioral deficits and evoked potential changes. Neurobiol Dis 6: 486–498.
   Google Scholar
• Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Rosenberger P, Fass RJ (1993). Neuropsychological per-formance in symptomatic and asymptomatic HIV infec-tion [see comments]. AIDS 7: 519–524.
   PubMed Web of Science ®Google Scholar
• Brew BJ, Pemberton L, Cunningham P, Law MG (1997). Lev-els of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. I Infect Dis 175: 963–966.
   PubMed Web of Science ®Google Scholar
• Chang L, Ernst T, Leonido-Yee M, Witt M, Speck O, Walot I, Miller EN (1999). Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV de-mentia [In Process Citation]. Neurology 53: 782–789.
   PubMed Web of Science ®Google Scholar
• Clements JE, Babas T, Mankowski JL, Suryanarayana K, Piatak Jr M, Tarwater PM, Lifson JD, Zink MC (2002). The central nervous system as a reservoir for simian im-munodeficiency virus (SW): steady-state levels of SW DNA in brain from acute through asymptomatic infec-tion. J Infect Dis 186: 905–913.
   PubMed Web of Science ®Google Scholar
• Clifford DB (2000). Human immunodeficiency virus-associated dementia. Arch Neurol 57: 321-324.d'Arminio Monforte A, Testa L, Adorni F, Chiesa E, Bini T, Moscatelli GC, Abeli C, Rusconi S, Sollima S, Balotta C, Musicco M, Galli M, Moroni M (1998). Clinical out-come and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced pa-tients in advanced stages of HIV-1 infection. AIDS 12: 1631–1637.
   Google Scholar
• Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, Young SA, Mills RG, Wachsman W, Wiley CA (1992). Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42: 1736–1739.
   PubMed Web of Science ®Google Scholar
• Desrosiers RC (1990). The simian immunodeficiency viruses. Annu Rev Immunol 8: 557–578.
   PubMed Web of Science ®Google Scholar
• Diesing TS, Swindells S, Gelbard H, Gendelman HE (2002). HIV-1-associated dementia: a basic science and clinical perspective. AIDS Read 12: 358–368.
   PubMedGoogle Scholar
• Dougherty RH, Skolasky RL Jr, McArthur JC (2002). Progres-sion of HIV-associated dementia treated with HAART. AIDS Read 12: 69–74.
   PubMedGoogle Scholar
• Dunlop O, Bjorklund RA, Abdelnoor M, Myrvang B. (1992). Five different tests of reaction time evaluated in HIV seropositive men. Acta Neurol Scand 86: 260–266.
   Google Scholar
• Ellis RJ, Ksia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA, Group HNRC (1997). Cerebrospinal fluid human im-munodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 42: 679–688.
   PubMed Web of Science ®Google Scholar
• Fox HS, Gold LH, Henriksen SJ, Bloom FE (1997). Simian immunodeficiency virus: a model for neuroAIDS. Neu-robiol Dis 4: 265–274.
   PubMedGoogle Scholar
• Gartner S (2000). HIV infection and dementia. Science 287: 602–604.
   PubMed Web of Science ®Google Scholar
• Gendelman HE, Lipton SA, Tardieu M, Bukrinsky MI, Nottet HS (1994). The neuropathogenesis of HIV-1 in-fection [see comments]. J Leukoc Biol 56: 389–398.
   PubMed Web of Science ®Google Scholar
• Gendelman HE, Zheng J, Coulter CL, Ghorpade A, Che M, Thylin M, Rubocki R, Persidsky Y, Hahn F, Reinhard J Jr, Swindells S (1998). Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. /Infect Dis 178: 1000–1007.
   PubMed Web of Science ®Google Scholar
• Glass JD, Wesselingh SL, Selnes OA, McArthur JC (1993). Clinical-neuropathologic correlation in HIV-associated dementia [see comments]. Neurology 43: 2230–2237.
   PubMedGoogle Scholar
• Gold LH, Fox HS, Henriksen SJ, Buchmeier MJ, Weed MR, Taffe MA, Huitron-Resendiz S, Horn TF, Bloom FE (1998). Longitudinal analysis of behavioral,neurophysiological, viral and immunological effects of Sly infection in rhesus monkeys. J Med Primatol 27: 104–112.
   PubMedGoogle Scholar
• Gray F, Hurtrel M, Hurtrel B. (1993). Early central ner-vous system changes in human immunodeficiency virus (HIV)-infection. Neuropathol Appl Neurobiol 19: 3–9.
   Google Scholar
• Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, Godfrey HP, Kirson DA, Grant 1(1994). Neuropsychological impairment in human im-munodeficiency virus infection: implications for em-ployment. HNRC Group. HIV Neurobehavioral Research Center [see comments]. Psychosom Med 56: 8–17.
   Google Scholar
• Hienz RD, Turkkan JS, Spear DJ, Sannerud CA, Kaminski BJ, Allen RP (1992). General activity in baboons mea-sured with a computerized, lightweight piezoelectric motion sensor: effects of drugs. Pharmacol Biochem Be-hav 42: 497–507.
   Google Scholar
• Hirsch VM, Lifson JD (2000). Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. Adv Pharmacol 49: 437–477.
   PubMedGoogle Scholar
• Horn TF, Huitron-Resendiz S, Weed MR, Henriksen SJ, Fox HS (1998). Early physiological abnormalities af-ter simian immunodeficiency virus infection. Proc Nail Acad Sci US A 95: 15072–15077.
   PubMedGoogle Scholar
• Karlsen NR, Reinvang I, Froland SS (1992). Slowed reac-tion time in asymptomatic HIV-positive patients. Acta Neurol Scand 86: 242–246.
   PubMed Web of Science ®Google Scholar
• Kaul M, Garden GA, Lipton SA (2001). Pathways to neu-ronal injury and apoptosis in HIV-associated dementia. Nature 410: 988–994.
   PubMed Web of Science ®Google Scholar
• Lane JH, Sasseville VG, Smith MO, Vogel P, Pauley DR, Heyes MP, Lackner AA (1996a). Neuroin-vasion by simian immunodeficiency virus co-incides with increased numbers of perivascular macrophages/microglia and intrathecal immune activa-tion. I NeuroVirol 2: 423–432.
   PubMed Web of Science ®Google Scholar
• Lane TE, Buchmeier MJ, Watry DD, Fox HS (1996b). Expres-sion of inflammatory cytokines and inducible nitric ox-ide synthase in brains of SIV-infected rhesus monkeys: applications to HIV-induced central nervous system dis-ease. Mol Med 2: 27–37.
   PubMed Web of Science ®Google Scholar
• Ledergerber B, Egger M, Opravil M, Telenti A, Hirschel B, Battegay M, Vernazza P, Sudre P, Flepp M, Furrer H, Francioli P, Weber R (1999). Clinical progression and virological failure on highly active antiretroviral ther-apy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet 353: 863–868.
   Google Scholar
• Li Q, Eiden LE, Cavert W, Reinhart TA, Rausch DM, Murray EA, Weihe E, Haase AT (1999). Increased expression of nitric oxide synthase and dendritic injury in simian im-munodeficiency virus encephalitis. J Hum Virol 2: 139–145.
   Google Scholar
• Mankowski JL, Flaherty MT, Spelman JP, Hauer DA, Didier PJ, Amedee AM, Murphey-Corb M, Kirstein LM, Munoz A, Clements JE, Zink MC (1997). Pathogene-sis of simian immunodeficiency virus encephalitis: vi-ral determinants of neurovirulence. J Virol 71: 6055–6060.
   PubMed Web of Science ®Google Scholar
• Mankowski JL, Queen SE, Tarwater PM, Fox KJ, Perry VH (2002). Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SW gp41. J Neuropathol Exp Neurol 61: 85–90.
   PubMedGoogle Scholar
• Marcario JK, Raymond LA, McKieman BJ, Foresman LL, Joag SV, Raghavan R, Narayan O, Cheney PD (1999a). Motor skill impairment in SIV-infected rhesus macaques with rapidly and slowly progressing disease. J Med Pri-matol 28: 105–117.
   Google Scholar
• Marcario JK, Raymond LA, McKieman BJ, Foresman LL, Joag SV, Raghavan R, Narayan O, Hershberger S, Cheney PD (1999b). Simple and choice reaction time perfor-mance in SIV-infected rhesus macaques. AIDS Res Hum Retroviruses 15: 571–583.
   Google Scholar
• Mark RF, Sperry RW (1968). Bimanual Coordination in Monkeys. Exp Neurol 21: 92–104.
   Google Scholar
• Martin A, Heyes MP, Salazar AM, Kampen DL, Williams J, Law WA, Coats ME, Markey SP (1992). Progressive slow-ing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected indi-viduals. J Neuropsychiaby Clin Neurosci 4: 270–279.
   PubMed Web of Science ®Google Scholar
• McArthur JC, McClemon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St. Clair M, Lanier ER (1997). Relationship between human immunodeficiency virus-associated de-mentia and viral load in cerebrospinal fluid and brain. Ann Neurol 42: 689–698.
   PubMed Web of Science ®Google Scholar
• Montgomery MM, Dean AF, Taffs F, Stott EJ, Lantos PL, Luthert PJ (1999). Progressive dendritic pathology in cynomolgus macaques infected with simian immunod-eficiency virus. Neuropathol Appl Neurobiol 25: 11–19.
   Google Scholar
• Murray EA, Rausch DM, Lendvay J, Sharer LR, Eiden LE (1992). Cognitive and motor impairments associated with SW infection in rhesus monkeys. Science 255: 1246–1249.
   PubMed Web of Science ®Google Scholar
• Nuovo GJ, Alfieri ML (1996). AIDS dementia is associated with massive, activated HIV-1 infection and concomi-tant expression of several cytokines. Mol Med 2: 358–366.
   PubMed Web of Science ®Google Scholar
• Pagano MA, Cahn PE, Garau ML, Mangone CA, Figini HA, Yorio AA, Dellepiane MC, Amores MG, Perez HM, Casiro AD (1992). Brain-stem auditory evoked poten-tials in human immunodeficiency virus-seropositive pa-tients with and without acquired immunodeficiency syndrome. Arch Neurol 49: 166–169.
   Google Scholar
• Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P (1988). The brain in AIDS: central nervous sys-tem HIV-1 infection and AIDS dementia complex. Sci-ence 239: 586–592.
   PubMed Web of Science ®Google Scholar
• Prospero-Garcia O, Gold LH, Fox HS, Polis I, Koob GF, Bloom FE, Henriksen SJ (1996). Microglia-passaged simian immunodeficiency virus induces neurophysio-logical abnormalities in monkeys. Proc Nail Acad Sci US A 93: 14158–14163.
   Google Scholar
• Rausch DM, Heyes MP, Murray EA, Lendvay J, Sharer LR, Ward JM, Rehm S, Nohr D, Weihe E, Eiden LE (1994). Cy-topathologic and neurochemical correlates of progres-sion to motor/cognitive impairment in SW-infected rhe-sus monkeys. J Neuropathol Exp Neurol 53: 165–175.
   PubMedGoogle Scholar
• Rausch DM, Murray EA, Eiden LE (1999). The SW-infected rhesus monkey model for HIV-associated dementia and implications for neurological diseases. I Leukoc Biol 65: 466–474.
   Google Scholar
• Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001). HIV-associated neurologic disease incidence changes: Mul-ticenter AIDS Cohort Study, 1990–1998. Neurology 56: 257–260.
   Google Scholar
• Sacktor N, McArthur J (1997). Prospects for therapy of HIV-associated neurologic diseases. I NeuroVirol 3: 89–101.
   PubMed Web of Science ®Google Scholar
• Sharer LR (1992). Pathology of HIV-1 infection of the central nervous system. A review. I Neuropathol Exp Neurol 51: 3–11.
   PubMed Web of Science ®Google Scholar
• Suarez S, Baril L, Stankoff B, Khellaf M, Dubois B, Lubetzki C, Bricaire F, Hauw JJ (2001). Outcome of patients with HIV-1-related cognitive impairment on highly active an-tiretroviral therapy. AIDS 15: 195–200.
   Google Scholar
• Weed MR, Gold LH (2001). Paradigms for behavioral as-sessment of viral pathogenesis. Adv Virus Res 56: 583–626.
   Google Scholar
• Wit FW, van Leeuwen R, Weverling GJ, Jurriaans S, Nauta K, Steingrover R, Schuijtemaker J, Eyssen X, Fortuin D, Weeda M, de Wolf F, Reiss P, Danner SA, Lange JM (1999). Outcome and predictors of failure of highly ac-tive antiretroviral therapy: one-year follow-up of a co-hort of human immunodeficiency virus type 1-infected persons. J Infect Dis 179: 790–798.
   Google Scholar
• Zink MC, Amedee AM, Mankowski JL, Craig L, Didier P, Carter DL, Munoz A, Murphey-Corb M, Clements JE (1997). Pathogenesis of Sly encephalitis. Selection and replication of neurovirulent Sly. Am I Pathol151: 793–803.
   Google Scholar
• Zink MC, Coleman GD, Mankowski JL, Adams RJ, Tarwater PM, Fox K, Clements JE (2001a). Increased macrophage chemoattractant protein-1 in cerebrospinal fluid pre-cedes and predicts simian immunodeficiency virus en-cephalitis. /Infect Dis 184: 1015–1021.
   PubMed Web of Science ®Google Scholar
• Zink MC, Coleman GD, Mankowski JL, Adams RJ, Tarwater PM, Fox K, Clements JE (2001b). Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. /Infect Dis 184: 1015–1021.
   PubMed Web of Science ®Google Scholar
• Zink MC, Spelman JP, Robinson RB, Clements JE (1998). SW infection of macaques—modeling the progression to AIDS dementia. I NeuroVirol 4: 249–259.
   Web of Science ®Google Scholar
• Zink MC, Suryanarayana K, Mankowski JL, Shen A, Piatak M Jr, Spelman JP, Carter DL, Adams RJ, Lifson JD, Clements JE (1999). High viral load in the cerebrospinal fluid and brain correlates with severity of simian im-munodeficiency virus encephalitis. J Virol 73: 10480–10488.
   PubMed Web of Science ®Google Scholar